Reading the tape
NASDAQ: SRTS
Sensus Healthcare, Inc.
Healthcare · Medical - Devices
Market Cap
$65.19M
52w High
$5.92
52w Low
$3.03
P/E
-8.38
Volume
118.07K
Outstanding Shares
16.46M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -2.7%Revenue (TTM): -34.26%FCF (TTM): 140.56%P/E: 0th pct
What changed
The stock fell 2.7% over the last year. Revenue declined 34.26% over the trailing twelve months. Operating margin moved from 19.35% to -37.5%. Free cash flow grew 140.56% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -37.5%. A decisive move in revenue — currently down 34.26% — would be the clearest signal to resolve the ambiguity.
Company profile
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.
CEOJoseph C. Sardano
SectorHealthcare
IndustryMedical - Devices
Employees54
IPO dateJul 26, 2016
Valuation
Forward P/E—
EV/EBITDA-4.39
Enterprise value$43.58M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-62.2%
Gross margin43.18%▼26.11%vs FY2024
Operating margin-37.5%▼293.81%vs FY2024
ROE-16.05%▼234.79%vs FY2024
Analyst consensus
RatingBuy
Target price$6.00▲51.52%
6
Buy
3
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est -$0.13 · Revenue est $5.32M
View